Current role
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Zhilin Li
Equibles does not estimate personal net worth.
Get an email with a short summary when China Pharma Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get CPHI alertsAbout Zhilin Li
Zhilin Li is recorded as CEO at China Pharma Holdings, Inc. (CPHI). The proxy statement of China Pharma Holdings, Inc. reports total compensation of $241,600 for Zhilin Li in fiscal 2020, including a base salary of $225,600. Disclosed compensation is on record for 3 fiscal years. China Pharma Holdings, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at China Pharma Holdings, Inc. includes Baowen Dong (Board Member), Gene Michael Bennett (Board Member) and Yingwen Zhang (Board Member).
Affiliation history
-
Current
Company network
Leadership on record at China Pharma Holdings, Inc.
- Baowen Dong Board Member
- Gene Michael Bennett Board Member
- Yingwen Zhang Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | China Pharma Holdings, Inc. (CPHI) | Chairman, Chief Executive Officer President and interim Chief Financial Officer | $225,600 | $241,600 |
| 2019 | China Pharma Holdings, Inc. (CPHI) | Chairman, Chief Executive Officer President and interim Chief Financial Officer | $225,600 | $241,600 |
| 2018 | China Pharma Holdings, Inc. (CPHI) | Chairman, Chief Executive Officer President and interim Chief Financial Officer | $225,600 | $241,600 |
Recent activity
No call appearances or filed executive changes recorded yet.